Select Page

Infinium Pharmachem IPO GMP, Price, Dates & Allotment Details 2023

Infinium Pharmachem IPO GMP, Price, Dates & Allotment Details 2023

As per the DRHP filed with SEBI, through Infinium Pharmachem IPO, the company intends to raise approximately  ₹ 25.31 crore through this public offering, consisting of 1,875,000 shares with a face value of  ₹ 10 each. Which will be issued at a price of  ₹ 135 per share.

Infinium Pharmachem Limited was incorporated in 2003. The company was incorporated with the objective of manufacturing and supplying iodine, iodine derivatives, and active pharmaceutical ingredients (APIs). The company was formed with a vision to be globally integrated and admired by the pharmaceutical and healthcare industries. 

The company got certified as ISO 9001-2008 in 2010. The company currently provides the widest range of iodine derivatives in the market, with more than 250 intermediates and 15+ active pharmaceutical ingredients. 

Objects of the Issue

The company proposes to utilise the net proceeds of the Fresh Issue towards funding the following objects:

  1. Marketing and branding expenses (including registration in Europe and other marketing expenses).
  2. Repayment of some of the existing loans and expansion of units
  3. To meet incremental working capital requirements.
  4. To meet public issue expenses.

Financial Highlights (Restated)

ParticularsPeriod ended on 30th Sep. 2022FY 2021-22FY 2020-21FY 2019-20
Net Worth1,8561,310702425
Total Assets7,0765,9003,4182,245
Total Borrowings1,6151,385579566
Total Revenue7,98510,0067,1153,942
Profit After Tax55161127293
(Amount in ₹ Lakhs)

Infinium Pharmachem IPO – Details

As per the DRHP filed with SEBI, a total of 18.75 lakh shares will be offered as part of the fresh issue on the NSE SME segment. The face value of the shares is ₹ 10. The market maker would receive 94,000 shares of the offering. While Swastika Investmart Limited will be the lead manager for the IPO, Bigshare Services Pvt Ltd will be the registrar. It will be a Fixed Price Issue IPO, so there will be a price at which the securities are offered or allotted is known in advance to the investor.

Issue TypeFixed Price Issue IPO
IPO Price₹ 135 per share
Face Value₹ 10 per share
Market Lot1,000 Shares
Issue Size1,875,000 shares of ₹ 10 each (Aggregating up to ₹ 25.31 Crore)
Fresh Issue1,875,000 shares of ₹ 10 each  (Aggregating up to ₹ 25.31 Crore)
Market MakerSwastika Investmart Limited
Market maker portion94,000 shares
Listing AtNSE SME
Company PromotersMr. Sanjaykumar Viththalbhai Patel,
Mr. Pravin Bhadabhai Madhani,
Mr. Mitesh Lavjibhai Chikhaliya

GMP – Infinium Pharmachem IPO

Infinium Pharmachem’ IPO GMP, or grey market premium, is available on this page. The IPO GMP is updated on a day-to-day basis during the running period of the IPO, due to which the GMP rates fluctuate and stabilise after some time. GMP rates are not 100% guaranteed. Please click here for GMP details.

Tentative Dates

Opening DateMarch 31, 2023
Closing DateApril 5, 2023
Basis of AllotmentApril 11, 2023
Initiation of RefundsApril 12, 2023
Credit of shares to Demat A/cApril 13, 2023
Listing DateApril 17, 2023

Lot Size – Infinium Pharmachem IPO

The lot size of the Infinium Pharmachem IPO is 1,000 shares. A retail-individual investor can apply for up to 1 lot, i.e. 1,000 shares of  ₹ 135,000.

ApplicationsLotsSharesAmount 
Retail (Minimum)11,000₹ 135,000
Retail (Maximum)11,000₹ 135,000
HNI (Minimum)22,000₹ 270,000

Promoters Holdings – Infinium Pharmachem IPO

Pre-issue Shares Holdings100%
Post-issue Shares Holdings

SWOT Analysis – Infinium Pharmachem IPO

STRENGTHSWEAKNESSES
1. Expertise of the company in research and development (R&D) (200+ iodine derivatives and 7 APIs researched and developed).
2. Strong process and chemistry skills.
3. Strong growth in emerging market businesses.
4. Having a sound competitive strategy and a keen eye on market gaps
5. Dependable suppliers: The company has a good quantity of competent raw material suppliers, which allows it to bypass many supply chain bottlenecks.
6. Strong marketing and sales force.
7. Expertise in iodination reactions.
8. Expanding reach to over 15+ countries across the globe while significantly increasing our customer base in India too.
9. small- and bulk-scale manufacturing capabilities to onboard a maximum customer base.
1. Low Market Penetration in New Markets: To penetrate international markets outside of the home country, i.e., India, the company has to spend more on promotional, marketing, and advertising efforts.
2. A sudden rise in demand for product baskets is leading to higher inventory costs and interest costs.
OPPORTUNITIESTHREATS
1. Increasing market size due to multiple product applications in industries like lithium batteries, solar PV cells, paints, etc.
2. Contract Research and Manufacturing Services (CRAMS): The company develops and manufactures the products specifically as per the customer’s requirements and final application.
3. widely untapped export market.
4. Companies can also expand into markets other than the pharmaceutical industry. 

1. Regulatory challenges, government policies, and tax procedures can have an impact on the margins.
2. competition from existing players.
3. Uncertain product-specific demand
4. An increase in raw material prices may result in curtailed margins.

Miscellaneous Information

Download Prospectus (PDF)IPO DRHP
Company Contact InformationInfinium Pharmachem Limited
38 G.I.D.C Sojitra,Taluka – Sojitra, Dist. – Anand – 387240
Phone: +91-2692-238849
Email: [email protected]
Website: https://infiniumpharmachem.com/
IPO RegistrarBigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: [email protected]
Website: https://www.bigshareonline.com/
IPO Lead Manager(s)Swastika Investmart Ltd 

FAQ’s

The Infinium Pharmachem Ltd. IPO price is ₹ 135 per share.

One lot of the Infinium Pharmachem Ltd. IPO contains 1,000 shares of ₹ 135,000.

The minimum investment size is one lot for retail investors.

The finalisation of the basis of allotment for the Infinium Pharmachem Ltd. IPO will be done on April 11, 2023, and the allotted shares will be credited to your demat account by April 13, 2023. Check the Infinium Pharmachem Ltd. IPO allotment status.

The Infinium Pharmachem Ltd. IPO shares listing date is April 17, 2023.

Click here for more FAQs.

Leave a reply

Your email address will not be published. Required fields are marked *

Current IPO (Main Board)

Issuer CompanyOpenClose
Tata Technologies Ltd.--
Plaza Wires Ltd.29-Sep-234-Oct-23
27-Sep-233-Oct-23
Updater Services Ltd.25-Sep-2327-Sep-23
JSW Infrastructure ltd.25-Sep-2327-Sep-23
22-Sep-2326-Sep-23
20-Sep-2322-Sep-23
20-Sep-2322-Sep-23
Yatra Online Ltd.15-Sep-2320-Sep-23
14-Sep-2318-Sep-23

SME IPO

Issuer CompanyOpenClose
Rajgor Castor Derivatives Ltd.17-Oct-2320-Oct-23
WomanCart Ltd.16-Oct-2318-Oct-23
12-Oct-2316-Oct-23
Committed Cargo Care Ltd.6-Oct-2310-Oct-23
29-Sep-234-Oct-23
Karnika Industries Ltd.29-Sep-234-Oct-23
Plada Infotech Services Ltd.29-Sep-234-Oct-23
29-Sep-234-Oct-23
29-Sep-234-Oct-23
Vivaa Tradecom Ltd.27-Sep-234-Oct-23

RECENT COMMENT